A Potential Contribution of Chemokine Network Dysfunction to the Depressive Disorders

Title:A Potential Contribution of Chemokine Network Dysfunction to the Depressive Disorders

Volume: 14 Issue: 7

Author(s): Joanna Ślusarczyk, Ewa Trojan, Jakub Chwastek, Katarzyna Głombik and Agnieszka Basta-Kaim

Affiliation:

Keywords: Antidepressant drugs, chemokine, chemokine receptors, depression, neuroinflammation, neuroplasticity, neuroendocrinology, neurotransmission.

Abstract: In spite of many years of research, the pathomechanism of depression has not yet been elucidated. Among many hypotheses, the immune theory has generated a substantial interest. Up till now, it has been thought that depression is accompanied by the activation of inflammatory response and increase in pro-inflammatory cytokine levels. However, recently this view has become controversial, mainly due to the family of small proteins called chemokines. They play a key role in the modulation of peripheral function of the immune system by controlling immune reactions, mediating immune cell communication, and regulating chemotaxis and cell adhesion. Last studies underline significance of chemokines in the central nervous system, not only in the neuromodulation but also in the regulation of neurodevelopmental processes, neuroendocrine functions and in mediating the action of classical neurotransmitters. Moreover, it was demonstrated that these proteins are responsible for maintaining interactions between neuronal and glial cells both in the developing and adult brain also in the course of diseases.

This review outlines the role of chemokine in the central nervous system under physiological and pathological conditions and their involvement in processes underlying depressive disorder. It summarizes the most important data from experimental and clinical studies.

Cite this article as:

Ślusarczyk Joanna, Trojan Ewa, Chwastek Jakub, Głombik Katarzyna and Basta-Kaim Agnieszka, A Potential Contribution of Chemokine Network Dysfunction to the Depressive Disorders, Current Neuropharmacology 2016; 14 (7) . https://dx.doi.org/10.2174/1570159X14666160219131357